Lupe Guerra
Physician Assistant · Lutz, FLNPI 1205319019
Payments from drug & device makers
Across 727 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Acadia Pharmaceuticals Inc$847
- Pfizer$837
- AbbVie$835
- MDD US Operations, LLC$833
- plus $10K from 52 others
What the payments were for
- Food & beverage$15,636100%
- Education$750%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,712 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 119 | $1,126,557 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 22 | $618,974 |
| NuplazidPimavanserin Tartrate | 47 | $229,168 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 16 | $200,302 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 20 | $164,359 |
| QuliptaAtogepant | 117 | $143,479 |
| Nurtec OdtRimegepant Sulfate | 64 | $125,396 |
| IngrezzaValbenazine Tosylate | 13 | $104,640 |
| AustedoDeutetrabenazine | 14 | $91,435 |
| Aimovig AutoinjectorErenumab-Aooe | 90 | $83,422 |
| CopaxoneGlatiramer Acetate | 12 | $68,584 |
| UbrelvyUbrogepant | 50 | $61,109 |
| BotoxOnabotulinumtoxina | 28 | $35,711 |
| XcopriCenobamate | 24 | $31,879 |
| Emgality PenGalcanezumab-Gnlm | 39 | $28,775 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $149 | $1,126,557119 claims |
| PfizerOctagam, Nurtec Odt | $837 | $744,37086 claims |
| AbbVieQulipta, Ubrelvy, Botox | $835 | $240,299195 claims |
| Acadia Pharmaceuticals IncNuplazid | $847 | $229,16847 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $406 | $200,30216 claims |
| CSL BehringPrivigen | $516 | $164,35920 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Copaxone | $710 | $160,01926 claims |
| Neurocrine Biosciences, Inc.Ingrezza, Ongentys | $1,015 | $129,91943 claims |
| SK Life Science, Inc.Xcopri | $604 | $31,87924 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $366 | $19,97036 claims |
| UCB, Inc.Briviact | $1,319 | $16,20112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Lutz
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.